Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Japon1003
Daisuke Hoshi9
Japon Sauf Daisuke Hoshi" 994
Daisuke Hoshi Sauf Japon" 0
Japon Et Daisuke Hoshi 9
Japon Ou Daisuke Hoshi 1003
Corpus6869
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
001726 Eiichi Tanaka [Japon] ; Eisuke Inoue [Japon] ; Rei Yamaguchi [Japon] ; Yoko Shimizu [Japon] ; Akiko Kobayashi [Japon] ; Naoki Sugimoto [Japon] ; Daisuke Hoshi [Japon] ; Kumi Shidara [Japon] ; Eri Sato [Japon] ; Yohei Seto [Japon] ; Ayako Nakajima [Japon] ; Shigeki Momohara [Japon] ; Atsuo Taniguchi [Japon] ; Hisashi Yamanaka [Japon]Pharmacoeconomic analysis of biological disease modifying antirheumatic drugs in patients with rheumatoid arthritis based on real-world data from the IORRA observational cohort study in Japan.
002073 Eiichi Tanaka [Japon] ; Eisuke Inoue ; Daisuke Hoshi ; Yoko Shimizu ; Akiko Kobayashi ; Naoki Sugimoto ; Kumi Shidara ; Eri Sato ; Yohei Seto ; Ayako Nakajima ; Shigeki Momohara ; Atsuo Taniguchi ; Hisashi YamanakaCost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study.
002091 Eri Sato [Japon] ; Eiichi Tanaka ; Moeko Ochiai ; Yoko Shimizu ; Akiko Kobayashi ; Kumi Shidara ; Daisuke Hoshi ; Naoki Sugimoto ; Eisuke Inoue ; Yohei Seto ; Ayako Nakajima ; Atsuo Taniguchi ; Shigeki Momohara ; Hisashi YamanakaChronological changes in baseline disease activity of patients with rheumatoid arthritis who received biologic DMARDs between 2003 and 2012.
002456 Yoshiya Tanaka [Japon] ; Tsutomu Takeuchi ; Koichi Amano ; Kazuyoshi Saito ; Kentaro Hanami ; Masao Nawata ; Shunsuke Fukuyo ; Hideto Kameda ; Yuko Kaneko ; Takahiko Kurasawa ; Hayato Nagasawa ; Daisuke Hoshi ; Eri Sato ; Hisashi YamanakaEffect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors.
002785 Daisuke Hoshi [Japon] ; Ayako Nakajima ; Kumi Shidara ; Yohei Seto ; Eiichi Tanaka ; Atsuo Taniguchi ; Shigeki Momohara ; Hisashi YamanakaDisability is the major negative predictor for achievement of Boolean-based remission in patients with rheumatoid arthritis treated with tocilizumab.
003501 Daisuke Hoshi [Japon] ; Ayako Nakajima ; Eisuke Inoue ; Kumi Shidara ; Eri Sato ; Mariko Kitahama ; Yohei Seto ; Eiichi Tanaka ; Wako Urano ; Naomi Ichikawa ; Yumi Koseki ; Shigeki Momohara ; Astuo Taniguchi ; Norihiro Nishimoto ; Hisashi YamanakaIncidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab.
003943 Hisashi Yamanaka [Japon] ; Yoshiya Tanaka ; Eisuke Inoue ; Daisuke Hoshi ; Shigeki Momohara ; Kentaro Hanami ; Naoki Yunoue ; Kazuyoshi Saito ; Kouichi Amano ; Hideto Kameda ; Tsutomu TakeuchiEfficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study).
003954 Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka ; Koichi Amano ; Daisuke Hoshi ; Masao Nawata ; Hayato Nagasawa ; Eri Sato ; Kazuyoshi Saito ; Yuko Kaneko ; Shunsuke Fukuyo ; Takahiko Kurasawa ; Kentaro Hanami ; Hideto Kameda ; Hisashi YamanakaClinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study.
003B95 Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Koichi Amano [Japon] ; Daisuke Hoshi [Japon] ; Masao Nawata [Japon] ; Hayato Nagasawa [Japon] ; Eri Sato [Japon] ; Kazuyoshi Saito [Japon] ; Yuko Kaneko [Japon] ; Shunsuke Fukuyo [Japon] ; Takahiko Kurasawa [Japon] ; Kentaro Hanami [Japon] ; Hideto Kameda [Japon] ; Hisashi Yamanaka [Japon]Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients-REACTION 52-week study

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021